HIF-1α-induced upregulated miR-322 forms a feedback loop by targeting Smurf2 and Smad7 to activate

Wei Dong1, Chen Dong1, Jianbing Zhu1

  • 1Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

Insights

MicroRNA-322 (miR-322) protects against myocardial ischemia/reperfusion injury (MIRI) by upregulating the Smad3/β-catenin pathway. This involves a feedback loop between beta-catenin and hypoxia-inducible factor alpha (HIF-1α).

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Cellular Signaling

Background:

  • Myocardial ischemia/reperfusion injury (MIRI) is a significant contributor to heart failure post-myocardial infarction.
  • The precise molecular mechanisms underlying miR-322's role in MIRI progression require further elucidation.

Purpose of the Study:

  • To investigate the role and molecular mechanism of microRNA-322 (miR-322) in regulating myocardial ischemia/reperfusion injury (MIRI).
  • To identify the key molecular targets and signaling pathways modulated by miR-322 during MIRI.

Main Methods:

  • Establishment of an MIRI cell model using oxygen-glucose deprivation/reoxygenation (OGD/R) in H9c2 cells.
  • Assessment of cell viability (MTS assay) and apoptosis (flow cytometry, TUNEL staining).
  • Verification of molecular interactions using dual-luciferase reporter gene assays.

Main Results:

  • miR-322 was significantly downregulated in OGD/R-treated cells; its overexpression enhanced cell viability and reduced apoptosis.
  • Smurf2 and Smad7 were identified as direct targets of miR-322, and their knockdown mimicked the protective effects of miR-322.
  • A positive feedback loop involving HIF-1α and β-catenin was identified, regulating miR-322 expression and activating the Smad3/β-catenin pathway.

Conclusions:

  • miR-322 plays a protective role in MIRI by targeting Smurf2 and Smad7, thereby activating the Smad3/β-catenin pathway.
  • The β-catenin/HIF-1α positive feedback loop contributes to the protective effects of miR-322 in MIRI, offering potential therapeutic targets.